GHO Capital Partners related stories
All articles and analysis
PE targets opportunities in nutraceuticals: 7 dealsButterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector.
Defence-adjacent tech front of mind for APGThe €601bn Dutch pension administrator is willing to pursue earlier-stage investments, including taking a more proactive stance towards European VC, global co-head of PE Greg Jania tells PEI.
Behind the scenes of the GHO and CBC healthcare mergerThe combination of the two firms, which will create the world's largest healthcare private equity investor, will change how healthcare investing is done by linking East and West opportunities, its co-chief executives tell PEI.
PE targets eye care assets: 6 dealsGoldman Sachs, Gryphon Investors, MidEuropa and Olympus are among the PE firms eying platform investments and consolidation in eye care.
PE-backed Alcami to acquire TjoapackHeadquartered in North Carolina, Alcami is a contract development and manufacturing organization.
GHO Capital sells specialty pharmaceutical provider VISUfarma to Lupin LimitedThe deal expands Lupin's presence in Europe, accelerate the buildout of its specialty franchise and is immediately accretive.
Agilent to buy Biocare Medical from Excellere and GHO CapitalThe deal is valued at $950 million.
Allianz Global, a major PE backer, cools on private equity in slow exit marketThe private equity business of the asset management arm of German insurer Allianz has grown from €18.5bn in AUM as of end-2020 to around €30bn this year.
GHO Capital acquires Scientist.comKevin Lustig serves as CEO of Scientist.com.
GHO Capital to take majority stake in FotoFinder Systems from EMZFotoFinder is an advanced skin imaging systems and AI-powered diagnostic software provider.